Stockreport

Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects [Yahoo! Finance]

Precigen, Inc.  (PGEN) 
Last precigen, inc. earnings: 3/2 04:05 pm Check Earnings Report
PDF Outperform rating on Precigen Inc. (NASDAQ:PGEN) and hiked the price target to $9 from $8. Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatm [Read more]